Physician profile
John K Cooke
NPI 1972510329
$7,359.23
in general payments reported to CMS, 2019-2025
10 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,073 · 2020: $654 · 2021: $973 · 2022: $787 · 2023: $1,447 · 2024: $1,043 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,443 · Travel and Lodging: $411 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,442.58 |
| Travel and Lodging | $411.48 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $4,594.70 | 2019-2025 | Total30, Precision 1, Precision7 |
| Bausch & Lomb Americas INC. | $902.28 | 2022-2025 | Infuse, Biotrue, Miebo |
| Johnson & Johnson Vision Care, INC. | $791.32 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $397.26 | 2019-2021 | |
| Coopervision INC. | $199.72 | 2020-2024 | Myday Contact Lens |
| Abb Con-Cise Optical Group LLC | $158.20 | 2019-2023 | Spectacle Lenses, Contact Lens |
| Glaukos Corporation | $144.83 | 2021 | |
| Sight Sciences, INC. | $141.89 | 2024 | Omni Surgical System |
| Allergan, INC. | $29.03 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cooke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.